Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frampton

Showing results (71-80 of 2,541) with videos related to

Pageof 255
Sort By:
Drugs|April 23, 2020
Correction to: Eculizumab: A Review in Neuromyelitis Optica Spectrum DisorderJames E Frampton
Drugs|May 20, 2017
Ocrelizumab: First Global ApprovalJames E Frampton
The American Journal of Nursing|February 26, 2009
Creating a patient-centered systemSusan B Frampton
Paediatric Drugs|May 21, 2010
Mifamurtide: a review of its use in the treatment of osteosarcomaJames E Frampton
American Journal of Respiratory and Critical Care Medicine|July 19, 2011
Ozone air pollution: how low can you go?Mark W Frampton
Physical Review. D, Particles and Fields|October 15, 1986
Regularization of open superstring from orientable closed surfaceFrampton, Kshirsagar, Ng
Acta Crystallographica. Section C, Crystal Structure Communications|November 7, 2013
An introduction to the special issue on pharmaceuticals, drug discovery and natural productsChristopher S Frampton
Drugs|November 12, 2014
Pramipexole extended-release: a review of its use in patients with Parkinson's diseaseJames E Frampton
CNS Drugs|August 22, 2015
Erratum to: Oxycodone/Naloxone PR: A Review in Severe Refractory Restless Legs SyndromeJames E Frampton
Drugs|September 29, 2020
Atezolizumab: A Review in Extensive-Stage SCLCJames E Frampton
Pageof 255

Showing results (71-80 of 2,541) with videos related to

Sort By:
Pageof 255
Drugs|April 23, 2020
Correction to: Eculizumab: A Review in Neuromyelitis Optica Spectrum DisorderJames E Frampton
Drugs|May 20, 2017
Ocrelizumab: First Global ApprovalJames E Frampton
The American Journal of Nursing|February 26, 2009
Creating a patient-centered systemSusan B Frampton
Paediatric Drugs|May 21, 2010
Mifamurtide: a review of its use in the treatment of osteosarcomaJames E Frampton
American Journal of Respiratory and Critical Care Medicine|July 19, 2011
Ozone air pollution: how low can you go?Mark W Frampton
Physical Review. D, Particles and Fields|October 15, 1986
Regularization of open superstring from orientable closed surfaceFrampton, Kshirsagar, Ng
Acta Crystallographica. Section C, Crystal Structure Communications|November 7, 2013
An introduction to the special issue on pharmaceuticals, drug discovery and natural productsChristopher S Frampton
Drugs|November 12, 2014
Pramipexole extended-release: a review of its use in patients with Parkinson's diseaseJames E Frampton
CNS Drugs|August 22, 2015
Erratum to: Oxycodone/Naloxone PR: A Review in Severe Refractory Restless Legs SyndromeJames E Frampton
Drugs|September 29, 2020
Atezolizumab: A Review in Extensive-Stage SCLCJames E Frampton
Pageof 255